• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov24
Gossamer Bio Inc. to Attend Piper Sandler Annual Healthcare Conference
21:01
Nov6
Gossamer Bio released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 34.67 M and EPS of USD -0.543
04:00
Gossamer Bio released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 13.29 M (forecast USD 6.381 M), actual EPS USD -0.2115 (forecast USD -0.1871)
04:00
Nov5
Gossamer Bio Inc. updates seralutinib development for pulmonary hypertension
21:37
Sep22
Gossamer Bio to Present Scientific Reports on Seralutinib at ERS Congress
11:31
Aug6
Gossamer Bio released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 11.49 M (forecast USD 5.409 M), actual EPS USD -0.1699 (forecast USD -0.1749)
03:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 13.29 M, Net Income -48.22 M, EPS -0.2115

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 11.49 M, Net Income -38.27 M, EPS -0.1699

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 9.889 M, Net Income -36.64 M, EPS -0.1615

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More